CD34+ stem cells for treatment of congestive heart failure
This study aims to assess the safety and efficacy, as determined by heart function, of autologous CD34+ stem cell delivery to congestive heart failure patients.
Read More
No additional information regarding the therapeutic cells was provided by the sponsor.
Read More
Product Information for
CD34+ stem cells for treatment of congestive heart failure